SWTXUnknownMid-Cap
SpringWorks Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for SpringWorks Therapeutics, Inc. (SWTX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are SWTX insiders buying or selling?
SpringWorks Therapeutics, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since September 2019, Trabud has recorded 55 Form 4 filings for SWTX: 5 buys ($14.4M) and 50 sells ($417.8M).
Source: SEC EDGAR Form 4
Key Statistics (September 2019 – Mar 5, 2025)
Total Form 4 filings
55
SEC EDGAR
Insider filers
13
Insider buys (5)
$14.4M
Insider sells (50)
$417.8M
Insider sentiment
Net sellingNet insider flow of $403.4M in net selling since September 2019.
Recent SWTX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Badreddin Edris | Chief Operating Officer | Sale | 20.0K | $54.23 | $1.1M | SEC ↗ |
| Mar 5, 2025 | Saqib Islam | Chief Executive Officer | Sale | 49.0K | $54.24 | $2.7M | SEC ↗ |
| Feb 24, 2025 | Saqib Islam | Chief Executive Officer | Sale | 29.3K | $60.30 | $1.8M | SEC ↗ |
| Feb 24, 2025 | Bhavesh Ashar | Chief Commercial Officer | Sale | 1.0K | $61.19 | $62.2K | SEC ↗ |
| Feb 24, 2025 | Daniel Lynch | Director | Sale | 47.6K | $60.22 | $2.9M | SEC ↗ |
| Feb 19, 2025 | Saqib Islam | Chief Executive Officer | Sale | 10.7K | $59.92 | $639.5K | SEC ↗ |
| Feb 19, 2025 | Daniel Lynch | Director | Sale | 400 | $60.00 | $24.0K | SEC ↗ |
| Feb 13, 2025 | Daniel Pichl | Chief People Officer | Sale | 29.8K | $54.36 | $1.6M | SEC ↗ |
| Feb 13, 2025 | Daniel Lynch | Director | Sale | 175.0K | $54.46 | $9.5M | SEC ↗ |
| Feb 13, 2025 | Saqib Islam | Chief Executive Officer | Sale | 48.0K | $53.30 | $2.6M | SEC ↗ |
| Feb 13, 2025 | Julie Hambleton | Director | Sale | 13.8K | $53.01 | $730.2K | SEC ↗ |
| Feb 13, 2025 | Badreddin Edris | Chief Operating Officer | Sale | 30.0K | $53.13 | $1.6M | SEC ↗ |
| Dec 5, 2024 | Badreddin Edris | Chief Operating Officer | Sale | 20.0K | $41.97 | $839.3K | SEC ↗ |
| Dec 4, 2024 | Saqib Islam | Chief Executive Officer | Sale | 49.0K | $41.37 | $2.0M | SEC ↗ |
| Sep 4, 2024 | Saqib Islam | Chief Executive Officer | Sale | 49.0K | $40.57 | $2.0M | SEC ↗ |
| Sep 4, 2024 | Badreddin Edris | Chief Operating Officer | Sale | 20.0K | $40.65 | $813.0K | SEC ↗ |
| Jun 5, 2024 | Saqib Islam | Chief Executive Officer | Sale | 49.0K | $39.90 | $2.0M | SEC ↗ |
| Jun 5, 2024 | Julie Hambleton | Director | Sale | 4.6K | $40.03 | $186.0K | SEC ↗ |
| Jun 5, 2024 | Badreddin Edris | Chief Operating Officer | Sale | 20.0K | $40.07 | $801.4K | SEC ↗ |
| Feb 20, 2024 | Daniel Pichl | Chief People Officer | Sale | 15.0K | $50.10 | $751.5K | SEC ↗ |
| Feb 6, 2024 | Bhavesh Ashar | Chief Commercial Officer | Sale | 8.1K | $47.34 | $381.4K | SEC ↗ |
| Feb 6, 2024 | Daniel Pichl | Chief People Officer | Sale | 26.2K | $44.32 | $1.2M | SEC ↗ |
| Jul 21, 2023 | Julie Hambleton | Director | Sale | 2.4K | $29.31 | $70.9K | SEC ↗ |
| Jun 22, 2023 | Julie Hambleton | Director | Sale | 2.4K | $26.92 | $64.6K | SEC ↗ |
| Mar 20, 2023 | Jeffrey Lawrence Schwartz | Director | Sale | 1.8M | $28.50 | $49.9M | SEC ↗ |
Showing the 25 most recent of 55 Form 4 filings for SpringWorks Therapeutics, Inc..
Most active SWTX insiders
- Saqib Islam12 filings
- ORBIMED ADVISORS LLC9 filings
- Badreddin Edris7 filings
- Julie Hambleton5 filings
- Daniel Pichl4 filings
Ask anything about SWTX insider activity
Use Trabud's AI agent to query SpringWorks Therapeutics, Inc.'s Form 4 history in plain English — "Show me SWTX CEO purchases this year" or compare it against any other ticker.
Open the AI agentSWTX insider trading FAQ
Are SpringWorks Therapeutics, Inc. insiders buying or selling?
SpringWorks Therapeutics, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since September 2019, Trabud has recorded 55 Form 4 filings for SWTX: 5 buys ($14.4M) and 50 sells ($417.8M). Over the full record that is net selling of $403.4M.
How many insiders trade SWTX stock?
13 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for SpringWorks Therapeutics, Inc.. The most recent filing was accepted on Mar 5, 2025.
Where does Trabud get SWTX insider trading data?
All SWTX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.